Oscar Health, Inc. (OSCR)

Oscar Health Stock Forecast

Stock Price Forecast

According to 7 professional analysts, the 12-month price target for Oscar Health stock ranges from a low of $11 to a high of $25. The average analyst price target of $14.86 forecasts a -11.39% decrease in the stock price over the next year.

Price Target: $14.86 (-11.39%)

Analyst Consensus: Sell

Target	Low	Average	Median	High
Price	$11	$14.86	$13	$25
Change	-34.41%	-11.39%	-22.48%	+49.08%

Analyst Ratings

The average analyst rating for Oscar Health stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	0	0	0	0	0	0
Buy	1	0	0	0	1	1
Hold	1	2	2	3	2	2
Sell	4	4	4	4	3	3
Strong Sell	1	1	1	1	1	1
Total	7	7	7	8	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jessica Tassan Piper Sandler	Piper Sandler	Hold → Buy Upgrades $13 → $25	Hold → Buy	Upgrades	$13 → $25	+49.08%	Nov 26, 2025
Stephen Baxter Wells Fargo	Wells Fargo	Sell Maintains $14 → $11	Sell	Maintains	$14 → $11	-34.41%	Nov 13, 2025
Andrew Mok Barclays	Barclays	Sell Maintains $11 → $13	Sell	Maintains	$11 → $13	-22.48%	Nov 10, 2025
Jonathan Yong UBS	UBS	Strong Sell Maintains $11 → $12	Strong Sell	Maintains	$11 → $12	-28.44%	Nov 7, 2025
Scott Fidel Goldman Sachs	Goldman Sachs	Hold Initiates $17	Hold	Initiates	$17	+1.37%	Oct 14, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

12.28B

Increased by 33.80%

from 9.18B

Revenue Next Year

11.56B

Decreased by -5.84%

from 12.28B

EPS This Year

-1.47

from 0.10

EPS Next Year

-0.43

from -1.47

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	390.99M	1.89B	3.96B	5.86B	9.18B	12.28B	11.56B
Revenue Growth	-17.79%	384.43%	109.27%	47.92%	56.54%	33.80%	-5.84%
EPS	-14.16	-3.20	-2.85	-1.22	0.10	-1.47	-0.43
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028
High	12.7B	12.7B
Avg	12.3B	11.6B
Low	11.7B	10.7B

Revenue Growth

Revenue Growth	2025	2026	2027	2028
High	38.6%	3.7%
Avg	33.8%	-5.8%
Low	27.2%	-13.0%

EPS Forecast

EPS	2025	2026	2027	2028
High	-1.23	0.17
Avg	-1.47	-0.43
Low	-1.87	-1.04

EPS Growth

EPS Growth	2025	2026	2027	2028
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.